Skip to main content

Effect of Food

2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Wockhardt
WockhardtNJ - Parsippany
1 program
1
Oral WCK2349Phase 11 trial
Active Trials
NCT01875939Completed12Est. Jun 2013
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
esomeprazole/ASA Fixed Dose CombinationPhase 11 trial
Active Trials
NCT01163630Completed24Est. Sep 2010
Qilu Pharmaceutical
Qilu PharmaceuticalChina - Jinan
1 program
QLC1101PHASE_11 trial
Active Trials
NCT06980909Not Yet Recruiting18Est. Aug 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Qilu PharmaceuticalQLC1101
WockhardtOral WCK2349
AstraZenecaesomeprazole/ASA Fixed Dose Combination

Clinical Trials (3)

Total enrollment: 54 patients across 3 trials

NCT06980909Qilu PharmaceuticalQLC1101

The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects

Start: Jun 2025Est. completion: Aug 202518 patients
Phase 1Not Yet Recruiting
NCT01875939WockhardtOral WCK2349

Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers

Start: Jun 2013Est. completion: Jun 201312 patients
Phase 1Completed
NCT01163630AstraZenecaesomeprazole/ASA Fixed Dose Combination

Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg

Start: Jun 2010Est. completion: Sep 201024 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.